Keyphrases
Multiple Myeloma
100%
Massive Bleeding
100%
Bleeding Disorders
100%
Thrombin Inhibitor
100%
Thrombin Time
100%
Bleeding
50%
Thrombin
50%
Activated Partial Thromboplastin Time (aPTT)
50%
Antithrombin
50%
IgG Concentration
50%
Hemorrhagic Complications
25%
High Concentration
25%
Chromogenic Substrate
25%
Plasmapheresis
25%
Vitamin K
25%
Prothrombin
25%
Coagulation Factors
25%
Sepharose
25%
Fibrinogen
25%
Monoclonal Gammopathy
25%
Antibody-associated
25%
Hydrolysis Rate
25%
Clinical Bleeding
25%
Pooled Plasma
25%
Fibrin Polymerization
25%
Immobilized Thrombin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Thrombin
100%
Bleeding Disorder
100%
Thrombin Inhibitor
100%
Bleeding
57%
Batroxobin
42%
Thromboplastin
28%
Antithrombin
28%
Sepharose
14%
Protein G
14%
Fibrinogen
14%
Blood Clotting Factor
14%
Prothrombin
14%
Vitamin K Group
14%
Chromogenic Substrate
14%
Monoclonal Immunoglobulinemia
14%